9621 Agnes Crossing, Lake Suzanneview, New Mexico Island 84604-9295.
If you’re following healthcare revenue cycle news, here’s the state of play in 2026: automation has stopped being optional, denial rates keep climbing at many US health systems,
If you’re following healthcare revenue cycle news, here’s the state of play in 2026: automation has stopped being optional, denial rates keep climbing at many US health systems, and AI tools are now handling billing tasks that used to sit firmly with human staff. This is a US-focused topic at its core, since revenue cycle work describes the insurance-based billing chain running from patient registration through to final payment, something the NHS’s funding model doesn’t mirror in the same way.
Even so, plenty of UK readers have good reason to keep an eye on this space: health-tech vendors selling into the US, outsourcing and BPO firms handling back-office billing for American clients, and investors tracking a sector that’s grown fast on automation spending. This roundup covers what’s actually changed recently, how RPA and AI are reshaping the work, and where to find reliable, current coverage going forward.
Revenue cycle work, the subject of most healthcare revenue cycle news you’ll find, is the process healthcare systems use to track revenue from a patient’s first appointment through to final payment of any balance. It spans patient registration, insurance verification, charge capture, medical coding, claim submission, payment posting, and accounts receivable follow-up.
Every stage carries real financial risk if it goes wrong. Errors anywhere in the chain can lead to delayed payments or no payment at all, which explains why so much current healthcare revenue cycle news centres on automation and AI, both pitched as ways to catch and prevent those errors before they cost a hospital money.
A few clear patterns run through recent coverage from trade press like Becker’s Hospital Review, HFMA and Healthcare Finance News.
The US healthcare industry avoided an estimated $258 billion in unnecessary administrative spending through automation and electronic transactions in 2024 alone, according to figures cited by automation vendors, worth treating as directional given they come from the sector itself rather than an independent audit. What’s clearer is the trajectory: some industry voices now expect the majority of revenue cycle management to eventually be handled by an AI agent rather than a human working through each step manually.
Prior authorisation has become one of healthcare’s most expensive administrative bottlenecks, slowing patient access, adding labour-intensive work, increasing denial risk, and putting pressure on reimbursement and cash flow across hospitals and health systems. Almost every major trade publication covering this space keeps returning to prior authorisation as the clearest example of a process built for automation, since much of the payer-provider back and forth follows predictable, rules-based steps.
Mid-2026 trade press has tracked a steady run of leadership moves and structural shifts across the sector. Recent coverage has included health systems dropping Medicare Advantage plans, hospitals naming new revenue cycle vice presidents, and ongoing debate over where automation still can’t beat the human touch in the revenue cycle. That last point is worth remembering when evaluating any vendor’s automation claims, since even the most enthusiastic coverage tends to admit that judgement-heavy work, like complex denial appeals, still benefits from experienced staff.
This is the technical thread running through most recent coverage, so it’s worth explaining properly rather than treating it as a buzzword.
Robotic process automation is a technology that uses bots or programs to imitate how a human interacts with software to complete high-volume, repeatable tasks, such as logging into applications, entering data, and copying data between systems. Inside a revenue cycle team specifically, RPA can automatically retrieve patient data from electronic health records, verify insurance eligibility, submit claims to insurance companies, and follow up on claim denials, tasks that previously needed a staff member to move manually between several separate software systems.
The tasks best suited to RPA share the same shape: repetitive, rules-based, high-volume. This includes claims processing, eligibility verification, payment posting, and denial management, freeing staff to focus on cases that genuinely need human judgement, like negotiating a disputed claim or resolving an unusual coding issue. One widely cited example describes a healthcare organisation that reduced errors and sped up processing after implementing an RPA solution, improving workflow costs by 68% and medical record inquiry turnaround time by 72% within months.
Current coverage is fairly upfront about the limits here. RPA may not be fully compatible with other commonly used systems and programs, and there are ongoing issues with securing the data it processes, which matters given how much sensitive patient and financial information flows through these bots daily. RPA also depends on stable, well-defined processes, when payer rules or coding requirements shift frequently, a rigid bot can amplify errors rather than prevent them, at least until it’s retrained.
Denial rates are one of the most closely watched figures in this space, and the trend isn’t encouraging for providers. Coverage throughout 2026 keeps returning to denial management, referral leakage, and front-end access gaps as top financial concerns. One estimate from Innovaccer research suggests a 400-bed health system loses $6.2 million annually from avoidable referral leakage alone, giving a sense of the financial scale involved even before denials are factored into the picture.
This is exactly where RPA and AI tools get pitched hardest to hospital finance leaders, since automated eligibility checks and coding validation can catch many denial triggers before a claim is even submitted, rather than fighting a denial after the fact.
A handful of names come up repeatedly across current coverage as the biggest players shaping automation adoption in this space: Optum, R1 RCM, Ensemble Health Partners, Waystar, and a growing list of AI-focused start-ups pitching agent-based billing tools. Recent Becker’s coverage has also tracked major technology partnerships, including Optum’s partnership with Anthropic and reporting on Anthropic’s Claude being used to handle healthcare claims and care management tasks, which shows how quickly large language model tools are being trialled alongside more traditional RPA. Consulting firms like Huron and McKinsey also feature heavily in reporting on how health systems are structuring these automation investments at scale.
If you’re following healthcare revenue cycle news because of a vendor relationship, an outsourcing contract, or an investment interest, a few practical points are worth keeping front of mind. The sheer complexity of US healthcare billing, shaped by hundreds of different payer rules, is exactly why RCM automation has become such a large market there, a complexity the NHS’s single-payer model simply doesn’t replicate. If you’re evaluating a vendor claiming RPA or AI capability for revenue cycle work, ask specifically which stages of the cycle their tool covers and what error rate reduction they can actually document, rather than relying on industry-wide savings figures that may not reflect that vendor’s real-world performance.
It typically covers billing automation, denial rate trends, prior authorisation bottlenecks, staffing and leadership changes at health systems, and new technology partnerships. Most coverage is US-focused, tied to the country’s insurance-based billing system.
Robotic process automation uses software bots to handle repetitive, rules-based billing tasks like data entry, eligibility verification and claim submission, mimicking steps a human employee would otherwise carry out manually. It’s currently one of the most widely adopted technologies in revenue cycle operations.
Denial rates directly affect a hospital’s cash flow, and current reporting suggests they remain a persistent, costly problem across many US health systems. Automation and AI are being pitched heavily as ways to catch denial triggers before claims are even submitted.
Estimates vary widely by source, with some industry figures citing 25% to 50% in potential savings, though these numbers often come from vendors or industry bodies rather than independent audits. Real results depend heavily on which specific processes get automated and how well the rollout is managed.
Not in the same sense. The NHS runs largely on direct government funding rather than per-claim insurance billing, so it doesn’t face the same denial and reimbursement complexity that drives US healthcare revenue cycle work, though private UK healthcare providers do handle their own billing processes at a smaller scale.
Becker’s Hospital Review’s revenue cycle newsletter, HFMA’s revenue cycle topic page, and Healthcare Finance News all publish frequently updated, trade-press-level coverage. These tend to be more reliable than vendor blog content, which often mixes real reporting with product marketing.
Optum, R1 RCM, Ensemble Health Partners and Waystar are among the most frequently mentioned names in current coverage, alongside a growing wave of AI-focused start-ups building agent-based billing tools. Consulting firms like Huron and McKinsey also appear regularly, advising health systems on how to structure these automation investments.
